BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL
Clinical trial NCT04690595 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04690595
- Sponsor
- PeproMene Bio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-18
- Primary completion
- 2026-11-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.